Publication number: 20230241241
Abstract: This invention relates to conjugates of camptothecin analogs with a cell-binding molecule of formula (I), wherein R1, R2, R3, R4, R5, X, L, n, m, T and ----- are defined herein. It also provides methods of making the conjugates of camptothecin analogs to a cell-binding agent, as well as methods of using the conjugates in targeted treatment of cancer, infection, and immunological disorders.
Type:
Application
Filed:
June 19, 2020
Publication date:
August 3, 2023
Applicant:
HANGZHOU DAC BIOTECH CO., LTD.
Inventors:
Robert ZHAO, Qingliang YANG, Hangbo YE, Yuanyuan HUANG, Yifang XU, Gengxiang ZHAO, Diancheng CHEN, Huihui GUO, Xiangfei KONG, Wenjun LI, Lu BAI, Xiang CAI, Xiuzhen ZHANG, Junxiang JIA, Zhixiang GUO, Shangma HUANG, Xiaoxu WANG, Jun ZHENG, Yong DU, Yanhua LI, Yunxia ZHENG, Chen LIN, Xiaoxiao CHEN, Wei ZHENG, Xinyan JIANG, Lingli ZHANG, Riping YE, Miaomiao CHEN
Publication number: 20230115871
Abstract: The present invention relates to the conjugation of cytotoxic drug to a cell-binding molecule with a side-chain linker. It provides side-chain linkage methods of making a conjugate of a cytotoxic molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and immunological disorders.
Type:
Application
Filed:
June 24, 2019
Publication date:
April 13, 2023
Applicant:
Hangzhou DAC Biotech Co., Ltd
Inventors:
Robert Yongxin ZHAO, Qingliang YANG, Linyao ZHAO, Yuanyuan HUANG, Hangbo YE, Shun GAI, Junxiang JIA, Lu BAI, Wenjun LI, Zhixiang GUO, Chen LIN, Jun ZHENG, Huihui GUO, Minjun CAO, Xiangfei KONG, Yong DU, Yifang XU, Xiaomai ZHOU, Hongsheng XIE, Xiuzhen ZHANG, Miaomiao CHEN, Xiaolei LIU, Xiang CAI, Binbin CHEN, Yanlei YANG, Lingli ZHANG
Publication number: 20220249594
Abstract: A formulation of conjugates of tubulysin analogs with a cell-binding molecule having a structure represented by Formula (I), wherein T, L, m, n, ----, R1, R2, R3, R4, R1, R6, R7, R1, R9, R10, R11, R12, and R13 are as defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
Type:
Application
Filed:
February 18, 2020
Publication date:
August 11, 2022
Applicant:
HANGZHOU DAC BIOTECH CO., LTD
Inventors:
Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Huihui GUO, Lu BAI, Wenjun LI, Junxiang JIA, Zhixiang GUO, Jun ZHENG, Xiaoxiao CHEN, Xiangfei KONG, Chen LIN, Yong DU, Yu ZHANG, Lei ZHOU, Xiuzhen ZHANG, Xiuhong ZHENG, Binbin CHEN, Yanlei YANG, Meng DAI, Yifang XU, Zhongliang FAN, Xiaomai ZHOU, Xingyan JIANG, Miaomiao CHEN, Lingli ZHANG, Yanhua LI